Search hospitals > Oregon > Portland

Providence Portland Medical Center

Claim this profile
Portland, Oregon 97213
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
578 reported clinical trials
37 medical researchers
Photo of Providence Portland Medical Center in PortlandPhoto of Providence Portland Medical Center in PortlandPhoto of Providence Portland Medical Center in Portland

Summary

Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Providence Portland Medical Center is involved with conducting 578 clinical trials across 587 conditions. There are 37 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.

Area of expertise

1Parotid Gland Cancer
Global Leader
Providence Portland Medical Center has run 155 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Providence Portland Medical Center has run 94 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Providence Portland Medical Center

Breast Cancer
Lung Cancer
Breast cancer
Parotid Gland Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Multiple Myeloma
Ovarian Cancer
Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Sacituzumab Tirumotecan + Pembrolizumab

for Breast Cancer

The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Providence Portland Medical Center?
Where is Providence Portland Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Providence Portland Medical Center accept?
What awards or recognition has Providence Portland Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security